Biosci Rep:Th22 / Treg细胞失衡导致接受血液透析的尿毒症患者微炎症

2020-02-27 不详 网络

调节性T(Treg)细胞在接受血液透析(HD)的尿毒症患者的免疫激活和炎症中具有至关重要的功能。Treg细胞平衡的破坏具有引起感染性疾病进展的潜能。在这里,我们检查了HD患者中Th22 / Treg细胞比例失衡与微炎症之间的可能联系。分离外周血单个核细胞(PBMC),以使用流式细胞仪测量Th22细胞和Treg细胞的百分比。随后,通过酶联免疫吸附剂测定相关细胞因子,白细胞介素(IL)22(IL-22

调节性T(Treg)细胞在接受血液透析(HD)的尿毒症患者的免疫激活和炎症中具有至关重要的功能。Treg细胞平衡的破坏具有引起感染性疾病进展的潜能。在这里,我们检查了HD患者中Th22 / Treg细胞比例失衡与微炎症之间的可能联系。

分离外周血单个核细胞(PBMC),以使用流式细胞仪测量Th22细胞和Treg细胞的百分比。随后,通过酶联免疫吸附剂测定相关细胞因子,白细胞介素(IL)22(IL-22)和IL-10的血清水平以及炎性因子,C反应蛋白(CRP),(TNF-α),IL-6分析(ELISA)。然后评估透析时间,微炎症状态(CRP)和透析充分性(免疫反应性甲状旁腺激素(iPTH),尿素清除指数(Kt / V),β2-MG,血清钙和血清磷)之间的关系。最后,利用皮尔逊相关系数分析了微炎症状态与透析充分性之间的相关性。

结果显示,在进行HD的尿毒症患者中,Th22的百分比升高,Treg细胞的百分比降低。血清IL-22,CRP,TNF-α和IL-6水平升高,而IL-10血清水平降低。在接受HD治疗的尿毒症患者中,Th22 / Treg细胞失衡与微炎症状态有关。此外,改变了透析时间的延长,微炎症状态和透析充分性。观察到透析充分性增加与接受HD的尿毒症患者微炎症减轻有关。

总之,Th22 / Treg细胞失衡可能是引起尿毒症发生的潜在原因,这反过来表明通过改变Th22 / Treg细胞的比例或可有效地缓解尿毒症。

原始出处:

Tingting Ren, Jingyuan Xiong, et al., Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis. Biosci Rep. 2019 Oct 30; 39(10): BSR20191585. doi: 10.1042/BSR20191585

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-08-15 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-02-29 habb
  4. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
    2020-02-29 tcm99hq
  5. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1918999, encodeId=b263191899964, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 15 12:03:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670535, encodeId=9d2516e053581, content=<a href='/topic/show?id=7bc54e43473' target=_blank style='color:#2F92EE;'>#尿毒症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47434, encryptionId=7bc54e43473, topicName=尿毒症患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b24f26728715, createdName=chenwq17, createdTime=Sun Mar 15 21:03:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262547, encodeId=38b9126254e87, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290430, encodeId=de371290430b5, content=<a href='/topic/show?id=facb4e432e4' target=_blank style='color:#2F92EE;'>#尿毒症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47432, encryptionId=facb4e432e4, topicName=尿毒症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343525, encodeId=edd7134352571, content=<a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17788, encryptionId=7dd51e788b8, topicName=Treg细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477202, encodeId=6e3014e720208, content=<a href='/topic/show?id=81f91e786ce' target=_blank style='color:#2F92EE;'>#Treg#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17786, encryptionId=81f91e786ce, topicName=Treg)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96827361646, createdName=12498484m48(暂无昵称), createdTime=Sat Feb 29 14:03:00 CST 2020, time=2020-02-29, status=1, ipAttribution=)]